Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients

Транскатетерная или хирургическая замена аортального клапана у пациентов промежуточного риска
Kevin L. Greason, Wilson Y. Szeto, Lars Georg Svensson, Dean J. Kereiakes, David J. Cohen, Martin B. Leon, Jeffrey W. Moses, John G. Webb, William Fuller Fearon, Emin Murat Tuzcu, Wael A. Jaber, Samir Ramesh Kapadia, Vasilis C. Babaliaros, Susheel Kodali, Alan Zajarías, Augusto Descalzi Pichard, Raj Makkar, Brian K. Whisenant, Michael J. Mack, Howard C. Herrmann, Vinod H. Thourani, David Craig Miller, Rebecca Tung Hahn, Philippe Pîbarot, Darshan Doshi, Mathew Russell Williams, Alfredo Trento, Craig R. Smith, David L. Brown, Todd M. Dewey, Maria C. Alu, Robert W. Hodson, William N. Anderson
2016-04-02

intermediate-risk patientsnoninferiority trialsevere aortic stenosissurgical aortic-valve replacementtranscatheter aortic-valve replacement
BACKGROUND: Previous trials have shown that among high-risk patients with aortic stenosis, survival rates are similar with transcatheter aortic-valve replacement (TAVR) and surgical aortic-valve replacement. We evaluated the two procedures in a randomized trial involving intermediate-risk patients. METHODS: We randomly assigned 2032 intermediate-risk patients with severe aortic stenosis, at 57 centers, to undergo either TAVR or surgical replacement. The primary end point was death from any cause or disabling stroke at 2 years. The primary hypothesis was that TAVR would not be inferior to surgical replacement. Before randomization, patients were entered into one of two cohorts on the basis of clinical and imaging findings; 76.3% of the patients were included in the transfemoral-access cohort and 23.7% in the transthoracic-access cohort. RESULTS: The rate of death from any cause or disabling stroke was similar in the TAVR group and the surgery group (P=0.001 for noninferiority). At 2 years, the Kaplan-Meier event rates were 19.3% in the TAVR group and 21.1% in the surgery group (hazard ratio in the TAVR group, 0.89; 95% confidence interval [CI], 0.73 to 1.09; P=0.25). In the transfemoral-access cohort, TAVR resulted in a lower rate of death or disabling stroke than surgery (hazard ratio, 0.79; 95% CI, 0.62 to 1.00; P=0.05), whereas in the transthoracic-access cohort, outcomes were similar in the two groups. TAVR resulted in larger aortic-valve areas than did surgery and also resulted in lower rates of acute kidney injury, severe bleeding, and new-onset atrial fibrillation; surgery resulted in fewer major vascular complications and less paravalvular aortic regurgitation. CONCLUSIONS: In intermediate-risk patients, TAVR was similar to surgical aortic-valve replacement with respect to the primary end point of death or disabling stroke. (Funded by Edwards Lifesciences; PARTNER 2 ClinicalTrials.gov number, NCT01314313.).
1
Among transfemoral-access patients, TAVR was associated with fewer deaths or disabling strokes than surgery; transthoracic-access outcomes were similar.
2
In 2032 intermediate-risk patients with severe aortic stenosis, TAVR was noninferior to surgery for death or disabling stroke at two years.
3
Surgery resulted in fewer major vascular complications and less paravalvular aortic regurgitation than TAVR.
4
TAVR provided larger aortic-valve areas and lower rates of acute kidney injury, severe bleeding, and new-onset atrial fibrillation.
5
Two-year death or disabling stroke rates were 19.3% with TAVR and 21.1% with surgery (hazard ratio, 0.89; 95% CI, 0.73–1.09).

Transcatheter aortic-valve replacement and surgical aortic-valve replacement in intermediate-risk patients with severe aortic stenosis

Comparative clinical outcomes and noninferiority of TAVR versus surgical replacement, including death or disabling stroke and procedure-related complications

Publication Details
Publication Date
2016-04-02
Journal
Publisher
ISSN
Cited by
5138
Access Type
Author Information
Authors
Kevin L. Greason
Wilson Y. Szeto
Lars Georg Svensson
Dean J. Kereiakes
David J. Cohen
Martin B. Leon
Jeffrey W. Moses
John G. Webb
William Fuller Fearon
Emin Murat Tuzcu
Wael A. Jaber
Samir Ramesh Kapadia
Vasilis C. Babaliaros
Susheel Kodali
Alan Zajarías
Augusto Descalzi Pichard
Raj Makkar
Brian K. Whisenant
Michael J. Mack
Howard C. Herrmann
Vinod H. Thourani
David Craig Miller
Rebecca Tung Hahn
Philippe Pîbarot
Darshan Doshi
Mathew Russell Williams
Alfredo Trento
Craig R. Smith
David L. Brown
Todd M. Dewey
Maria C. Alu
Robert W. Hodson
William N. Anderson
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%